文献速递结核与非结核分枝杆菌

儿童结核病诊断的宿主血液生物标志物:系统综述与荟萃分析

Host blood biomarkers for the diagnosis of childhood tuberculosis disease: a systematic review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2026-03-06

干扰素-γ诱导蛋白10的汇总灵敏度85.2%、特异度59.3%,未达WHO目标。

要点

  • 多数达标标志物仅来自单中心报告,需更大队列验证
  • 干扰素-γ诱导蛋白10汇总灵敏度85.2%、特异度59.3%,未达WHO目标

核心结论

  • 识别出达到WHO儿童结核病诊断目标的宿主血液生物标志物,但多数仅来自单中心报告。
  • 荟萃分析不支持干扰素-γ诱导蛋白10作为准确的独立生物标志物。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase、Cochrane CENTRAL、SCOPUS、ClinicalTrials.gov和WHO Global Index Medicus。
  • 纳入报告生物标志物浓度和/或诊断准确性的原创研究,对象为15岁以下接受结核病评估的儿童。
  • 采用分层双变量模型进行荟萃分析,偏倚风险评估使用QUADAS-2。

主要发现

  • 报告的生物标志物类别包括细胞因子/蛋白(39项研究)、mRNA(10项研究)、microRNA(4项研究)和其他(11项研究)。
  • 对7项研究的细胞因子干扰素-γ诱导蛋白10进行荟萃分析,汇总灵敏度85.2%(95% CI 71.1-93.1%),特异度59.3%(95% CI 44.7-72.5%),未达WHO目标产品概况。

关键数值与推荐

  • WHO结核病诊断目标产品概况:灵敏度≥95%,特异度>98%。
  • 参考标准为分枝杆菌培养、核酸扩增检测和/或临床诊断。
  • 纳入标准为15岁以下接受结核病评估的儿童,检测抗结核治疗前采集的宿主血液生物标志物。

临床怎么用

  • 部分宿主血液生物标志物达到WHO儿童结核病诊断目标,但需在更大队列中验证后方可用于临床决策。
  • 干扰素-γ诱导蛋白10不推荐作为独立的儿童结核病诊断标志物。
  • 未来应聚焦开发适合低资源环境的即时检测方法。

局限性

  • 多数达到WHO目标的生物标志物仅来自单中心报告。
  • 需要高质量研究在更大队列中验证宿主血液生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current tuberculosis (TB) diagnostics have limited sensitivity in children, resulting in undiagnosed and untreated cases; host blood biomarkers have the potential to narrow this diagnostic gap. OBJECTIVES: To conduct a systematic review to identify host blood biomarkers that diagnose childhood TB and to summarize biomarker accuracy. METHODS: DATA SOURCES: MEDLINE, Embase, Cochrane Central Register of Controlled Trials, SCOPUS, ClinicalTrials.gov, and WHO Global Index Medicus. STUDY ELIGIBILITY CRITERIA: Original studies that reported biomarker concentration and/or diagnostic accuracy for childhood TB. PARTICIPANTS: Children <15 years undergoing evaluation for TB disease. TESTS: Any host blood biomarker measured before anti-TB therapy. REFERENCE STANDARD: Mycobacterial culture, nucleic acid amplification tests, and/or clinical diagnosis. ASSESSMENT OF RISK OF BIAS: Quality Assessment of Diagnostic Accuracy Studies-2. METHODS OF DATA SYNTHESIS: A hierarchical bivariate model was used for meta-analysis. RESULTS: Fifty-five studies were included, of which 42 (76.4%) studies were at high risk of bias and/or had applicability concerns. The following biomarker classes were reported: cytokine/protein (n = 39 studies), mRNA (n = 10 studies), microRNA (n = 4 studies), and other (n = 11 studies). Twelve biosignatures (seven cytokine, four metalloproteinase, one microRNA) and two individual biomarkers (one cytokine, one metalloproteinase) met the WHO target product profile for TB disease diagnosis (sensitivity ≥95%, specificity >98%). Meta-analysis was conducted for the cytokine interferon-γ-inducible protein 10 from seven studies; summary estimates of sensitivity (85.2%, 95% CI, 71.1-93.1%) and specificity (59.3%, 95% CI, 44.7-72.5%) did not meet WHO target product profile. DISCUSSION: Host blood biomarkers were identified that met WHO targets for childhood TB disease diagnosis; however, most were reported from a single centre. Meta-analysis did not support interferon-γ-inducible protein 10 as an accurate stand-alone biomarker. High-quality studies are needed to validate host blood biomarkers in larger cohorts, and future work should focus on the development of point-of-care tests suitable for low-resource settings.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Prodanuk M, King JW, Cunningham J, et al. Host blood biomarkers for the diagnosis of childhood tuberculosis disease: a systematic review and meta-analysis. Clin Microbiol Infect. 2026. PMID: 41796962. doi:10.1016/j.cmi.2026.02.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。